Healthcare Realty Trust Incorporated

HRNYSEReal EstateREIT - Healthcare Facilities

$17.95- (-)1Y −4.01%

As of Oct 23, 2026 close

Market cap: $6.14B
P/E (TTM): -
Forward P/E: -
Dividend yield: 5.35%
52-week range: $16.31$22.04
Volume (live): -
Avg. volume (3M): 4.79M

Healthcare Realty Trust Incorporated (HR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Healthcare Realty Trust Incorporated stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Hold

Based on 10 unique analysts

(14 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$20.11

+12.03% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest HR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 20, 2026	Omotayo Okusanya	Deutsche Bank	Upgrades	Buy	$23.00
Oct 19, 2026	John Kilichowski	Wells Fargo	Reiterates	Hold	$20.00 → $18.00 −2.00 (−10.0%)
Oct 13, 2026	Michael Goldsmith	UBS	Reiterates	Hold	$21.00 → $18.00 −3.00 (−14.3%)
Oct 9, 2026	Michael Carroll	RBC Capital	Maintains	Hold	$22.00
Oct 8, 2026	Michael Carroll	RBC Capital	Maintains	Hold	$22.00
Sep 15, 2026	Joe Dickstein	Jefferies	Maintains	Hold	$20.00
Sep 2, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Sep 1, 2026	James Feldman	Wells Fargo	Reiterates	Hold	$21.00 → $20.00 −1.00 (−4.8%)
Aug 21, 2026	Michael Goldsmith	UBS	Reiterates	Hold	$21.00
Aug 17, 2026	Paul Choi	Goldman Sachs	Maintains	Hold	$14.00
Aug 16, 2026	Paul Choi	Goldman Sachs	Maintains	Hold	$14.00
Aug 7, 2026	Michael Carroll	RBC Capital	Maintains	Hold	$21.00 → $22.00 +1.00 (+4.8%)
Jul 31, 2026	Nicholas Yulico	Scotiabank	Maintains	Buy	$22.00
Jul 31, 2026	Richard Anderson	Cantor Fitzgerald	Reiterates	Buy	$22.00 → $24.00 +2.00 (+9.1%)

Omotayo Okusanya

Deutsche Bank

BuyUpgrades

$23.00

Oct 20

John Kilichowski

Wells Fargo

HoldReiterates

$20.00 → $18.00

Oct 19

Michael Goldsmith

UBS

HoldReiterates

$21.00 → $18.00

Oct 13

Michael Carroll

RBC Capital

HoldMaintains

$22.00

Oct 9

Michael Carroll

RBC Capital

HoldMaintains

$22.00

Oct 8

Joe Dickstein

Jefferies

HoldMaintains

$20.00

Sep 15

Zacks Equity Research

BuyInitiates Coverage

Sep 2

James Feldman

Wells Fargo

HoldReiterates

$21.00 → $20.00

Sep 1

Michael Goldsmith

UBS

HoldReiterates

$21.00

Aug 21

Paul Choi

Goldman Sachs

HoldMaintains

$14.00

Aug 17

Paul Choi

Goldman Sachs

HoldMaintains

$14.00

Aug 16

Michael Carroll

RBC Capital

HoldMaintains

$21.00 → $22.00

Aug 7

Nicholas Yulico

Scotiabank

BuyMaintains

$22.00

Jul 31

Richard Anderson

Cantor Fitzgerald

BuyReiterates

$22.00 → $24.00

Jul 31

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 20, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for HR?

The analyst consensus rating for HR is Hold, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for HR?

The average 12-month price target for HR is $20.11, representing an upside of 12.0% from the Oct 23, 2026 close of $17.95.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.